LOVFF's free cash flow for Q4 2023 was C$-2.41M. For the 2023 fiscal year, LOVFF's free cash flow was decreased by C$17.23M and operating cash flow was C$354.22K. See a summary of the company’s cash flow.

Cash Flow	TTM	Aug 23	Aug 22	Aug 21	Aug 20	Aug 19
Operating Cash Flow	C$ 6.11M	C$ 5.44M	C$ -6.08M	C$ -2.09M	C$ -9.32M	C$ -7.41M
Investing Cash Flow	C$ -8.47M	C$ -9.48M	C$ -15.35M	C$ -30.83M	C$ -8.55M	C$ -21.64M
Financing Cash Flow	C$ -1.74M	C$ -3.72M	C$ 25.46M	C$ 33.25M	C$ -914.82K	C$ 42.66M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	C$ 34.07M	C$ 9.02M	C$ 16.86M	C$ 8.16M	C$ 7.77M	C$ 26.51M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	-	-	-	C$ 24.30M	-	C$ 46.23M
Issuance Of Debt	C$ 3.25M	C$ 699.26K	C$ 26.63M	C$ 10.08M	C$ 6.00M	C$ 0.00
Repayment Of Debt	C$ -2.25M	C$ -2.30M	C$ -35.25M	C$ -616.34K	C$ -6.56M	C$ -235.45K
Free Cash Flow	C$ -2.55M	C$ -4.25M	C$ -21.48M	C$ -2.09M	C$ -18.64M	C$ -29.73M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in CAD

Cannara Biotech Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing